Snapshot
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
The global Precision Medicine market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Precision Medicine by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Diagnostics
Therapies
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Johnson & Johnson
IBM
GE Healthcare
Illumina
Roche
Laboratory Corporation of America Holdings
Thermo Fisher Scientific
Novartis
Abbott Laboratories
Almac Group
Intel Corporation
Biomrieux Sa
Cepheid
Qiagen
Randox Laboratories
Healthcore
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Oncology
Neurosciences
Immunology
Respiratory
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)